Literature DB >> 15957719

The effect of haemodilution on antithrombin concentration during cardiac surgery.

M D Linden1, N M Gibbs, M Bremner, M Schneider, W N Erber.   

Abstract

The effect of haemodilution on antithrombin concentration was investigated in 73 patients undergoing elective cardiac surgery with and without cardiopulmonary bypass. In patients who required cardiopulmonary bypass (n = 45), the antithrombin concentration fell to 52% of baseline during surgery (24.2 mg.dl(-1) to 12.6 mg.dl(-1)), and the haemoglobin level fell to 55% (136 g.l(-1) to 75 g.l(-1)). In patients who did not require cardiopulmonary bypass (n = 28), the antithrombin concentration fell to 82% of baseline (23.7 mg.dl(-1) to 19.5 mg.dl(-1)), and the haemoglobin concentration fell to 78% (141 g.l(-1) to 109 g.l(-1)). The overall correlation coefficient (r) for changes in antithrombin and haemoglobin concentrations was 0.76. The results indicate that most of the decrease in concentration of antithrombin during cardiac surgery is a consequence of cardiopulmonary bypass and is due to haemodilution. This data demonstrates that the percentage decrease in haemoglobin concentration can be used to estimate the percentage decrease in antithrombin concentration that occurs during cardiac surgery, if blood products that might effect the results are not administered between measurements.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15957719     DOI: 10.1177/0310057X0403200209

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  4 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

2.  Acute normovolemic hemodilution does not reduce antithrombin concentration for cardiac surgery.

Authors:  Matthew Dean Linden; Mark Schneider; Wendy Naomi Erber
Journal:  J Thromb Thrombolysis       Date:  2004-06       Impact factor: 2.300

3.  In vitro and in vivo effects of hemodilution on kaolin-based activated clotting time predicted heparin requirement using a heparin dose-response technique.

Authors:  Junko Ichikawa; Satoshi Hagihira; Testu Mori; Mitsuharu Kodaka; Keiko Nishiyama; Makoto Ozaki; Makiko Komori
Journal:  J Anesth       Date:  2016-08-08       Impact factor: 2.078

4.  Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium.

Authors:  Vicente Muedra; Lucrecia Moreno; Vicente Rodilla; Cristina Arce; Fermi Montó; Águeda Blázquez; Paloma Pérez; Pilar D'Ocón
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.